Table: begin end state 1 13 cytoplasmic 14 35 transmembrane 36 39 non-cytoplasmic 40 59 transmembrane 60 63 cytoplasmic 64 84 transmembrane 85 90 non-cytoplasmic 91 111 transmembrane 112 116 cytoplasmic 117 135 transmembrane 136 162 non-cytoplasmic 163 187 transmembrane 188 218 cytoplasmic 219 236 transmembrane 237 252 cytoplasmic 253 257 non-cytoplasmic 258 277 transmembrane 278 288 non-cytoplasmic 289 311 transmembrane 312 330 cytoplasmic 331 352 transmembrane 353 357 non-cytoplasmic 358 377 transmembrane 378 398 cytoplasmic 399 422 transmembrane 423 428 non-cytoplasmic 429 452 transmembrane 453 458 cytoplasmic 459 477 transmembrane 478 482 non-cytoplasmic 483 506 transmembrane 507 516 cytoplasmic 517 537 transmembrane 538 548 non-cytoplasmic 549 570 transmembrane 571 576 cytoplasmic 577 594 transmembrane 595 595 non-cytoplasmic
Input: >3607679 FitnessBrowser__Dino:3607679 MEAVEDRAVPRRQVWIALGALTVAFHLGLIFYGLVPNLVARPLHMALILPWVFLFAAATP VARISGAILTGLGIAGCLWIALNHQMLRNQYGFLESGFQVALAITLLLVAMEGARRAIGW PLPLVALLALLYGLYGQHIPGEFGHAGTPLRSFLGTLVVAEGGLWGSLTGVSVGVVAVFV IFGAVLNAGEAGQGFMNVAAAAAGRLKGGAAKVSVLSSALFGSISGSASANVASTGAITL PAMTKLGYPRRLAAATEAVASSGGQIMPPLMGAGAFVMVELTGVPYSEIMLAALLPAILY FATVWQGLNAFASRYDLRPIPVEDRPARRQVLITSGFFLVPFSTLLIAMFALGYTPQYAA ALAIFTGLALLFVDISLRPNPGQGFARLAEALLNAGKQVSMIAAIIICASIIIGVLGITG LGVKITSVILSGSGGALWPALLLTALACLLLGMEVPTTAAYVICVSVAGPALIELGLEPL QAHLFVFWFALLSTITPPVCGAVFIASGMVQENWLRVALTAMALGVGLYVIPLAMIANDA LIRLSAEPGAALLALLVVGAGLGGVSRGLIGREPWPLRVAVCAGGLGLCFAALWV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server